StocksSeagen IncSGEN

SGEN

Seagen Inc

137.00 0.17 (0.13%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado abierto
Invertir
V
137.00
C
137.95
Publicación incluida
Cancer-Med
Merck is in advanced talks to buy Seagen in a nearly $40 billion deal 🤝 🔸 Drugmaker $MRK (Merck & Co.) is reportedly in advanced talks to buy cancer-focused biotech company $SGEN (Seagen Inc) in a deal worth roughly $40 billion or more. The companies would be discussing a price above $200 a share... Mostrar más Traducir
Me gusta ComentarCompartir
null
.
Canal de mercado
Destacado